Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 4Phase 1 3Phase 1/2 1

Status

Completed 3Active not recruiting 3Enrolling by invitation 1

Sponsor Class

INDUSTRY 7

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 6Tumor-Agnostic 1

Conditions

Breast Neoplasms 70Neoplasms 7Neoplasm Metastasis 5Advanced Breast Cancer 5Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Neoplasms by Site 2Breast Neoplasms, Male 2Breast Diseases 2Skin Diseases 1Recurrence 1Quality of Life 1Low Grade Serous Ovarian Cancer 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Camurati-Engelmann Syndrome 1Breast Neoplasm Female 1Breast Cancer Metastatic 1Breast Cancer Female 1Bone Density 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Metastatic Breast Cancer 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Anastrozole × Clear all
NCT04964934 2026-04-21

SERENA-6

AstraZeneca

Phase 3 Active not recruiting
315 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT01602380 2026-02-27

FALCON

AstraZeneca

Phase 3 Completed
462 enrolled 20 charts
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04906395 2026-01-13

OVELIA

Tolmar Inc.

Phase 3 Active not recruiting
250 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Tolmar Inc.

Phase 3 Enrolling by invitation
250 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT04711252 2025-10-14

SERENA-4

AstraZeneca

Phase 3 Active not recruiting
1,370 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

AstraZeneca

Phase 3 Completed
197 enrolled 23 charts
Breast

Breast Neoplasms, Neoplasms

NCT00256698 2012-08-01

FACT

AstraZeneca

Phase 3 Completed
514 enrolled 13 charts
Breast

Breast Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡